Slide 1: YTD/Q3 2025 Results
YTD/Q3 2025 RESULTS OLIVIER RIGAUD (CEO) PETER KAZIUS (CFO) 29-Oct-2025
Slide 2: Forward-looking statements
YTD/Q3 2025 RESULTS This presentation contains forward-looking statements with respect to Corbion’s future performance and position. Such statements are based on current expectations, estimates, and projections of Corbion and information currently available to the company. Corbion cautions readers t
Slide 3: YTD/Q3 2025 Highlights
YTD/Q3 2025 RESULTS YTD/Q3 2025 Highlights • YTD Organic sales growth of +1.2% to € 957.2 million (Q3: € 311.6 million) Volume/mix • Volume/Mix +1.7% • Pricing -0.5% +1.7% (YTD) -1.5% (Q3) • YTD Adjusted EBITDA € 156.3 million (Q3: € 49.7 million) Adj. EBITDA margin • Health & Nutrition: Double-digi
Slide 4: Sales growth per segment in YTD/Q3 2025
YTD/Q3 2025 RESULTS Sales growth per segment in YTD/Q3 2025 Acq./ Total Sales growth Vol./Mix Price Organic Currency Div. growth YTD 2025 vs YTD 2024 - Functional Ingredients & Solutions +2.4% -0.9% +1.5% -2.5% -0.5% -1.5% - Health & Nutrition -0.8% +0.9% +0.1% -2.0% 0.0% -1.9% Total +1.7% -0.5% +1.
Slide 5: Sales and Adjusted EBITDA: YTD/Q3 2025
YTD/Q3 2025 RESULTS Sales and Adjusted EBITDA: YTD/Q3 2025 YTD YTD Q3 Q3 Growth € million 2025 2024 2025 2024 YTD Sales - Functional Ingredients & Solutions 739.8 751.3 242.3 254.1 -1.5% - Health & Nutrition 217.4 221.6 69.3 81.7 -1.9% Total Net Sales 957.2 972.9 311.6 335.8 -1.6% Adjusted EBITDA -
Slide 6: YTD Sales and Adjusted EBITDA development
YTD/Q3 2025 RESULTS YTD Sales and Adjusted EBITDA development Sales YTD Adjusted EBITDA YTD € million -1.6% € million 985 0 +15.2% 4 170 980 11 4 975 973 160 7 156 Q1: +€ 10 million 970 Q2: -€ 1 million 150 31 Q3: -€ 9 million 23 965 140 136 960 957 Q1: +€ 14 million 130 955 Q2: -€ 5 million Q3: +€
Slide 7: Functional Ingredients & Solutions
YTD/Q3 2025 RESULTS Functional Ingredients & Solutions Volume/mix (%) - Functional Ingredient & Solutions YTD YTD Organic Sales growth of +1.5% (Q3: +0.8%) +2.4% • Volume/mix +2.4% (Q3: +1.5%) Growth in Food mainly in meat and confectionary and in key product/market adjacencies and specialty prese
Slide 8: Health & Nutrition
YTD/Q3 2025 RESULTS Health & Nutrition Volume/mix (%) - Health & Nutrition YTD YTD organic Sales growth of +0.1% (Q3: -11.2%) -0.8% • Volume/mix -0.8% (Q3: -10.5%) Sales in the Nutrition business declined on reduced volume/mix in Q3 vs previous-year Q3 due to the very high comparable result from Q
Slide 9: TotalEnergies Corbion joint venture
YTD/Q3 2025 RESULTS TotalEnergies Corbion joint venture Sales - TotalEnergies Corbion Joint Venture YTD +4.3% € million YTD organic Sales growth of +4.3% (Q3: +1.6%) • Volume growth remains generally positive, mainly to food service applications in China YTD Adjusted EBITDA margin 9.0%, -200 bps (Q3
Slide 10: FY 2025 outlook affirmed
YTD/Q3 2025 RESULTS FY 2025 outlook affirmed Organic sales growth: • Volume/mix growth: +3-5% [previously +2-6%] Adjusted EBITDA organic growth >25% [unchanged] Free Cash Flow: >€85 million [unchanged] 10 29/10/2025
Slide 11: Annex
YTD/Q3 2025 RESULTS Annex 11 29/10/2025
Slide 12: Restatements - Continued Operations
YTD/Q3 2025 RESULTS Restatements - Continued Operations EBITDA € million 54.4 51.6 52.2 49.6 49.7 47.2 12.7 39.3 Discontinued Continued 34.5 Q1-2024 Q2-2024 Q3-2024 Q4-2024 Q1-2025 Q2-2025 Q3-2025 Average $US/€: 1.09 1.08 1.10 1.07 1.05 1.13 1.17 12 29/10/2025
Slide 13: Investor relations
Investor relations alex.sokolowski@corbion.com www.corbion.com +31 20 590 6341